@article{article, title = {{Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1}}, publisher = {{Springer Science and Business Media LLC}}, url = {{http://dx.doi.org/10.1007/s40257-023-00817-0 }}, year = {{2023}}, month = {{10}}, author = {{Simpson EL and Blauvelt A and Silverberg JI and Cork MJ and Katoh N and Mark T and Schneider SKR and Wollenberg A}}, doi = {{10.1007/s40257-023-00817-0}}, journal = {{American Journal of Clinical Dermatology}}, note = {{Accessed on 2025/06/26}}}